PPC
ELV icon

Park Place Capital’s Elevance Health ELV Stock Holding History

Park Place Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41K Sell
106
-1
-0.9% -$371 0.01% 465
2026
Q1 		$31.3K Buy
107
+50
+88% +$16.4K 0.01% 426
2025
Q4 		$20K Sell
57
-39
-41% -$13.2K ﹤0.01% 457
2025
Q3 		$31K Sell
96
-54
-36% -$16.8K 0.01% 401
2025
Q2 		$59.4K Sell
150
-32
-18% -$12.9K 0.01% 323
2025
Q1 		$79.2K Sell
182
-585
-76% -$235K 0.02% 288
2024
Q4 		$283K Sell
767
-79
-9% -$33.1K 0.08% 169
2024
Q3 		$440K Sell
846
-9
-1% -$4.81K 0.13% 140
2024
Q2 		$463K Buy
855
+393
+85% +$208K 0.15% 132
2024
Q1 		$240K Buy
462
+438
+1,825% +$218K 0.09% 212
2023
Q4 		$11.3K Sell
24
-157
-87% -$72.6K ﹤0.01% 610
2023
Q3 		$78.8K Sell
181
-1
-0.5% -$454 0.02% 393
2023
Q2 		$80.9K Sell
182
-1
-0.5% -$461 0.02% 403
2023
Q1 		$84.1K Buy
183
+12
+7% +$5.71K 0.02% 386
2022
Q4 		$88K Buy
+171
New +$86.8K 0.02% 379

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Park Place Capital's ELV Position: Q2 2026 in Review

Park Place Capital reduced its Elevance Health (ELV) stake by 0.93% in Q2 2026, selling an estimated $371 and leaving 106 shares worth $41K. The position accounts for 0.01% of the portfolio, ranked #465.

Park Place Capital first reported a position in ELV in Q4 2022 and has held it in 15 quarters since. The position peaked at $463K in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Park Place Capital held 106 shares of Elevance Health worth $41K as of Q2 2026.
  • Park Place Capital sold 1 Elevance Health share in Q2 2026, an estimated $371.
  • Elevance Health made up 0.01% of Park Place Capital's portfolio in Q2 2026, its #465 holding.
  • Park Place Capital first reported a position in Elevance Health in Q4 2022 and has held it in 15 quarters since.
  • Park Place Capital's Elevance Health position peaked at $463K in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.